Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Cardiff Oncology (CRDF.US)$ Risk Assessment CRDF is assess...

Risk Assessment
CRDF is assessed as a high-risk investment with a risk level score of 8/10. This elevated risk stems from the company's negative financial position, large operating losses, and heavy reliance on equity financing, which could lead to volatility and rapid changes in stock price. The Biotechnology sector's low appeal further contributes to the stock's risk, limiting investor interest. Short interest is high, suggesting a significant portion of investors expect the stock to decline. Although there are potential gains from recent trial results, the overall financial health and sector environment make it a precarious inclusion in a portfolio.
key attributes
recent earnings (yes), breakout(yes),catalyst (yes), valid float ( yes), dolla break ( yes), near 52 week high ( no), hot sector (no), good company ( no)
viability score : 6.65/10
Support and Resistance Levels
Support Level: $3.24, derived from clear support lines and stock consolidation history.
Resistance Level: $6.42, corresponding to its 52-week high, representing a significant barrier to upward movement.
Levels are valuable for setting entry and exit strategies and understanding potential price fluctuations.
Trading Strategy
With a trading score dictating a long bias, the strategy proposes leveraging $4,800 or 15.82% of a $10,000 fund. Entry at $3.25 is aligned with established support, offering a robust entry point. The exit at $6.637 targets near the resistance for maximizing profit. A stop loss at $2.327 helps mitigate losses if the stock underperforms, presenting a calculated risk-reward ratio of 1:3.67. This position seeks to balance potential upside from positive news with the tangible financial risks.
Equity: $10,000
Position Size: 480 shares
Entry Price: $3.25
Profitable Exit Price: $6.637
Stop Price: $2.327
Allocation of Capital: 15.82%
Risk/Reward Ratio: 1:3.67
Position Bias: Long

Conclusion

The assessment identifies CRDF as a cautious but plausible swing trading opportunity for risk-tolerant investors due to its chart characteristics and near-term catalysts. The stock's recent developments offer speculative upside potential, yet significant financial risks persist. Advice centers on maintaining a balanced risk approach, recommending restricted capital commitment given the current company and market conditions. Trades should incorporate strict entry, exit, and stop parameters to curb potential losses. This opportunity suits traders seeking higher risk/reward outcomes and can allocate capital wisely.
Final Verdict: Trade
Despite financial instability, CRDF offers a potential trading opportunity from a speculative angle, capitalizing on recent news and technical levels. Trade with a strategic plan to maximize potential while minimizing exposure to financial risks.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
Translate
Report
8449 Views
Comment
Sign in to post a comment